title: Re: Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure.
authors: Yu-Feng
authors: YF
authors: Lou
authors: Xin-Ping
authors: XP
authors: Shi
authors: Hui
authors: H
authors: Tong
authors: Guo-You
authors: GY
authors: Yu
authors: Geng-Dong
authors: GD
authors: Yao
authors: Kan
authors: K
authors: Dong
mesh_terms: D052242:Adiponectin / Q000097:blood; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002227:Carbazoles / Q000627:therapeutic use*; D000077261:Carvedilol; D002908:Chronic Disease; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D011412:Propanolamines / Q000627:therapeutic use*; D013318:Stroke Volume / Q000187:drug effects; D016896:Treatment Outcome; D016277:Ventricular Function, Left / Q000187:drug effects
chemical_list: C499918:ADIPOQ protein, human; D052242:Adiponectin; D000319:Adrenergic beta-Antagonists; D015415:Biomarkers; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol